Details of the Drug

General Information of Drug (ID: DMW4G68)

Drug Name

RG-201

Indication

Disease Entry	ICD 11	Status	REF
Acquired immune deficiency syndrome	1C62.3	Discontinued in Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Pneumocystis jirovecii DNA topoisomerase 2 (PJ top2)	TT1D5X3	L0P818_PNEJ8	Modulator	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005845)
2	US patent application no. 2004,0023,290, Novel therapeutic agents that modulate enzymatic processes.